Abstract:A novel assay of Norfloxacin with a sensitivity at the microgram level is proposed based on the measurement of enhanced fluorescence intensity signals by the interaction of functionalized nano-CdS with Norfloxacin. The CdS nanoparticles were synthesized by thioacetamide (TAA) and cadmium nitrate (Cd(NO3)2) in the alkaline solution, and the nanoparticles proved to be stable in the aqueous solution. At pH 7.4, the fluorescence signals of functionalized nano-CdS were greatly enhanced by Norfloxacin in the region of 300-700 nm characterized by the peak around 495 nm, and the surface defect-related emission located at 565 nm. However, the surface defect-related emission was unconspicuous, thus we concluded that the functionalized nano-CdS QDs (Quantum Dots) possessed excellent luminescence capability and favourable structure. At the same time, the absorption spectra and transmission electron microscopy (TEM) also proved this deduction. The external reaction conditions (such as effect of buffer system, pH, ionic strength, reaction time and temperature, colloid concentration) were discussed. The result showed that better fluorescence signals could be obtained in the condition of 0.10 mol x L(-1) Tris-HCl, pH 7.4, 0.1 mol x L(-1) NaCl and the reaction time 5 min. The fluorescence emission spectra of CdS QDs with increasing Norfloxacin concentration were recorded under the optimal condition. From the fluorescence intensity and peak position of nano-CdS colloidal as different concentration of Norfloxacin was added, the possible mechanism of reaction between mercapto-acetic acid capped CdS and Norfloxacin was discussed. Linear relationship can be established between the enhanced fluorescence intensity and Norfloxacin concentration in the range of 1.25-11.25 microg x mL(-1) (3.92-35.27 micromol x L(-1)) or 11.25-100.0 microg x mL(-1) (35.27-313.5 micromol x L(-1)). The limit of detection is 1.5 x 10(-3) x microg x mL(-1), which can be applied to the determination of blood serum samples. Based on this, a new direct quantitative determination method for Norfloxacin in synthetic samples without separation of foreign substances is established. At the same time, the possible enhancing mechanism is due to the formation of exciplex during reaction between nano-CdS and Norfloxacin, providing a guidance for the study of pharmacokinetics.

Identification of the Enzyme Responsible for N-Acetylation of Norfloxacin by Microbacterium sp. Strain 4N2-2

NorA Functions As a Multidrug Efflux Protein in Both Cytoplasmic Membrane Vesicles and Reconstituted Proteoliposomes

Isolation and Characterization of a Norfloxacin-Degrading Bacterial Strain Aeromonas Hydrophila Sp. N215-1

Expression of norA, norB and norC efflux pump genes mediating fluoroquinolones resistance in MRSA isolates

Adaptation of a fluoroquinolone-sensitive Shigella sonnei to norfloxacin exposure

A novel enrofloxacin-degrading fungus, Humicola sp. KC0924g, isolated from the rhizosphere sediment of the submerged macrophyte Vallisneria spiralis L.

Identification of a Novel Fosfomycin-Resistant UDP-N-acetylglucosamine Enolpyruvyl Transferase (mura) from a Soil Metagenome.

Characterization of a Key Aminoglycoside Phosphotransferase in Gentamicin Biosynthesis.

Development of monoclonal antibody against Norfloxacin

N-Formimidoylation/-iminoacetylation modification in aminoglycosides requires FAD-dependent and ligand-protein NOS bridge dual chemistry

Mechanism of norfloxacin transformation by horseradish peroxidase and various redox mediated by humic acid and microplastics

Performance of the Nitrogen Removal, Bioactivity and Microbial Community Responded to Elevated Norfloxacin Antibiotic in an Anammox Biofilm System

Determination of Norfloxacin by Its Enhancement Effect on the Fluorescence Intensity of Functionalized Cds Nanoparticles

Identification and characterization of a novel 6′-N-aminoglycoside acetyltransferase AAC(6′)-Va from a clinical isolate of Aeromonas hydrophila

Identification of novel natural inhibitor for NorM – a multidrug and toxic compound extrusion transporter – an insilico molecular modeling and simulation studies

Characterization and Removal Mechanism of a Novel Enrofloxacin-degrading Microorganism, Microbacterium proteolyticum GJEE142 Capable of Simultaneous Removal of Enrofloxacin, Nitrogen and Phosphorus

Identification and Functional Analysis of a Nitrate Assimilation Operon Nasackbdef from Amycolatopsis Mediterranei U32

Synthesis, Characterization, Molecular Docking, and Antimicobial Activities of Some New Sulfur containing Norfloxacin Analogues

Characterization of a SAM-dependent fluorinase from a latent biosynthetic pathway for fluoroacetate and 4-fluorothreonine formation in Nocardia brasiliensis.

Inhibition of norfloxacin on anaerobic digestion: Focusing on the recoverability and shifted microbial communities

Impacts of Norfloxacin on Sewage Sludge Anaerobic Digestion: Bioenergy Generation and Potential Environmental Risks